tiprankstipranks
Advertisement
Advertisement
Kringle Pharma’s KP-100IT Receives U.S. FDA Orphan Drug Designation for Spinal Cord Injury
PremiumCompany AnnouncementsKringle Pharma’s KP-100IT Receives U.S. FDA Orphan Drug Designation for Spinal Cord Injury
10M ago
Kringle Pharma Reports Financial Decline in First Half of 2025
Premium
Company Announcements
Kringle Pharma Reports Financial Decline in First Half of 2025
11M ago
Kringle Pharma Releases Updated Analyst Report to Enhance Investor Insight
Premium
Company Announcements
Kringle Pharma Releases Updated Analyst Report to Enhance Investor Insight
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100